- Home
- OSUR vs NCZ Comparison
OSUR vs NCZ Comparison
Compare OSUR & NCZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- NCZ
- Stock Information
- Founded
- OSUR 2000
- NCZ 2003
- Country
- OSUR United States
- NCZ United States
- Employees
- OSUR N/A
- NCZ N/A
- Industry
- OSUR Medical/Dental Instruments
- NCZ Finance Companies
- Sector
- OSUR Health Care
- NCZ Finance
- Exchange
- OSUR Nasdaq
- NCZ Nasdaq
- Market Cap
- OSUR 229.7M
- NCZ 228.3M
- IPO Year
- OSUR 1986
- NCZ N/A
- Fundamental
- Price
- OSUR $3.22
- NCZ $13.83
- Analyst Decision
- OSUR Hold
- NCZ
- Analyst Count
- OSUR 1
- NCZ 0
- Target Price
- OSUR $3.00
- NCZ N/A
- AVG Volume (30 Days)
- OSUR 607.0K
- NCZ 533.0K
- Earning Date
- OSUR 11-05-2025
- NCZ 01-01-0001
- Dividend Yield
- OSUR N/A
- NCZ 12.16%
- EPS Growth
- OSUR N/A
- NCZ N/A
- EPS
- OSUR N/A
- NCZ N/A
- Revenue
- OSUR $138,533,000.00
- NCZ N/A
- Revenue This Year
- OSUR N/A
- NCZ N/A
- Revenue Next Year
- OSUR $5.35
- NCZ N/A
- P/E Ratio
- OSUR N/A
- NCZ N/A
- Revenue Growth
- OSUR N/A
- NCZ N/A
- 52 Week Low
- OSUR $2.36
- NCZ $2.50
- 52 Week High
- OSUR $4.60
- NCZ $3.15
- Technical
- Relative Strength Index (RSI)
- OSUR 52.52
- NCZ 69.95
- Support Level
- OSUR $3.25
- NCZ $13.70
- Resistance Level
- OSUR $3.37
- NCZ $13.92
- Average True Range (ATR)
- OSUR 0.13
- NCZ 0.10
- MACD
- OSUR -0.00
- NCZ 0.02
- Stochastic Oscillator
- OSUR 23.81
- NCZ 81.79
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About NCZ Virtus Convertible & Income Fund II of Beneficial Interest
Virtus Convertible & Income Fund II is a diversified, closed-end management investment company. The investment objective of the company is to provide total return through a combination of capital appreciation and high current income. Its portfolio of investments includes different sector investments such as in healthcare services, media, oil, gas, and consumable fuels and others.